Evaluation of pharmacotherapy use in secondary prevention for patients with coronary heart disease one year after coronary angiography

被引：0
|
作者：
Kreicburga, L
Latkovskis, G
Kalnins, U
机构：
[1] Latvian State Univ, Fac Med, LV-1001 Riga, Latvia
[2] P Stradins Clin Univ Hosp, Latvian Ctr Cardiol, LV-1002 Riga, Latvia
来源：
ATHEROSCLEROSIS SUPPLEMENTS | 2004年 / 5卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
引用
收藏
页码：24 / 24
页数：1
相关论文
共 50 条
  • [31] SECONDARY PREVENTION OF CORONARY HEART-DISEASE
    ROBINSON, K
    MULCAHY, R
    IRISH MEDICAL JOURNAL, 1984, 77 (09) : 300 - &
  • [32] Periodontal and coronary heart disease in patients undergoing coronary angiography
    Berent, Robert
    Auer, Johann
    Schmid, Peter
    Krennmair, Gerald
    Crouse, Stephen F.
    Green, John S.
    Sinzinger, Helmut
    von Duvillard, Serge P.
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2011, 60 (01): : 127 - 133
  • [33] Pharmacotherapy of hypertension patients with coronary ischemic disease qualified for angiography
    Marcin Wirtwein
    Wojciech Sobiczewski
    Ivan Kocic
    Pharmacological Reports, 2013, 65 (Suppl 1) : 99 - 99
  • [34] A comparison of secondary prevention practice in poststroke and coronary heart disease patients
    Vanek, J.
    Mayer, O., Jr.
    Seidlerova, J.
    Bruthans, J.
    Kielbergerova, L.
    Wohlfahrt, P.
    Krajcoviechova, A.
    Filipovsky, J.
    Cifkova, R.
    PUBLIC HEALTH, 2016, 137 : 64 - 72
  • [35] Secondary Prevention and Quality of Life of Patients with Stable Coronary Heart Disease
    Zharkova, E. D.
    Lukina, Yu. V.
    Kutishenko, N. P.
    Huseynova, E. T.
    Zolotareva, N. P.
    Martsevich, S. Yu.
    Drapkina, O. M.
    Working Grp Register PROFILE
    RATIONAL PHARMACOTHERAPY IN CARDIOLOGY, 2023, 19 (02) : 167 - 172
  • [36] 5-Year evaluation of electronic medical record flag alerts for patients warranting secondary prevention of coronary heart disease
    Whitley, HP
    Fermo, JD
    Chumney, ECG
    PHARMACOTHERAPY, 2006, 26 (05): : 682 - 688
  • [37] The 'diet heart' hypothesis in secondary prevention of coronary heart disease
    deLorgeril, M
    Salen, P
    Monjaud, I
    Delaye, J
    EUROPEAN HEART JOURNAL, 1997, 18 (01) : 13 - 18
  • [38] Use of Evidence-Based Pharmacotherapy for Secondary Prevention of Coronary Heart Disease:A Chinese Medicine Hospital Versus A General Hospital
    徐慧敏
    蔡宏文
    戴海斌
    颜小锋
    周权
    徐耕
    黄兆铨
    毛威
    Chinese Journal of Integrative Medicine, 2014, (05) : 375 - 380
  • [39] Use of evidence-based pharmacotherapy for secondary prevention of coronary heart disease: A Chinese medicine hospital versus a general hospital
    Xu Hui-min
    Cai Hong-wen
    Dai Hai-bin
    Yan Xiao-feng
    Zhou Quan
    Xu Geng
    Huang Zhao-quan
    Mao Wei
    CHINESE JOURNAL OF INTEGRATIVE MEDICINE, 2014, 20 (05) : 375 - 380
  • [40] Use of evidence-based pharmacotherapy for secondary prevention of coronary heart disease: A Chinese medicine hospital versus a general hospital
    Hui-min Xu
    Hong-wen Cai
    Hai-bin Dai
    Xiao-feng Yan
    Quan Zhou
    Geng Xu
    Zhao-quan Huang
    Wei Mao
    Chinese Journal of Integrative Medicine, 2014, 20 : 375 - 380
12345